Covered recipient · General Payments record
SARAH DAWN ALLENDE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$1,292.15
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $669.41 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $256.77 | 8 |
| SHIELD THERAPEUTICS INC | $151.73 | 3 |
| Novo Nordisk AS | $74.84 | 3 |
| IBSA Pharma Inc. | $46.63 | 3 |
| Lilly USA, LLC | $46.08 | 3 |
| Astellas Pharma US Inc | $34.58 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.74 | 1 |
| Antares Pharma, Inc. | $18.87 | 1 |
| Organon LLC | $16.17 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.36 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106429608 | CMS |
| ABBVIE INC. | $124.64 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106429610 | CMS |
| ABBVIE INC. | $32.93 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106429612 | CMS |
| ABBVIE INC. | $23.66 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106429614 | CMS |
| ABBVIE INC. | $9.63 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106429616 | CMS |
| ABBVIE INC. | $23.55 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106429618 | CMS |
| ABBVIE INC. | $7.49 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106429620 | CMS |
| ABBVIE INC. | $25.51 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106429622 | CMS |
| Antares Pharma, Inc. | $18.87 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146494581 | CMS |
| Astellas Pharma US Inc | $16.86 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139503205 | CMS |
| Astellas Pharma US Inc | $17.72 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139467690 | CMS |
| IBSA Pharma Inc. | $15.61 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983010 | CMS |
| IBSA Pharma Inc. | $15.79 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983012 | CMS |
| IBSA Pharma Inc. | $15.23 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974855 | CMS |
| Lilly USA, LLC | $15.43 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135931744 | CMS |
| Lilly USA, LLC | $16.95 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135862403 | CMS |
| Lilly USA, LLC | $13.70 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135941028 | CMS |
| Novo Nordisk Inc | $23.05 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100560277 | CMS |
| Novo Nordisk Inc | $19.62 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100421569 | CMS |
| Novo Nordisk Inc | $32.17 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100558565 | CMS |
| Organon Llc | $6.78 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136298119 | CMS |
| Organon Llc | $9.39 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136298121 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.74 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153692098 | CMS |
| SHIELD THERAPEUTICS INC | $23.05 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150136089 | CMS |
| SHIELD THERAPEUTICS INC | $65.36 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150139147 | CMS |
| SHIELD THERAPEUTICS INC | $63.32 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150151794 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.